Congress trades and big insider sales, sent the day they're filed. Free.
Open in TelegramOfficers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 9 | King Terri GayDirector | Grant or award | A | — 3 sh | Jul 2, 2026 |
| 9 | Jones Bryn LlywelynDirector | Option exercise | M | — 5,118 sh | Jul 2, 2026 traded Jul 1, 2026 |
| 9 | Bonanni Mark EmilioEVP, CRO, Commercial | Option exercise | M | — 4,507 sh | Jul 2, 2026 traded Jul 1, 2026 |
| 9 | Brown Christopher (John)President, TTEC Digital | Tax withholding | F | $456 217 sh | Jul 2, 2026 traded Jul 1, 2026 |
| 9 | Lynch Andrew CharlesEVP & Chief Financial Officer | Grant or award | A | — 1,364 sh | Jul 2, 2026 traded Jul 1, 2026 |
| 9 | Petty JoshuaEVP & General Counsel | Tax withholding | F | $15K 244 sh | Jul 2, 2026 traded Jun 30, 2026 |
| 9 | Bazar Gregory MatthewDirector | Grant or award | A | — 5,524 sh | Jul 2, 2026 traded Jun 30, 2026 |
| 9 | Munroe GavinDirector | Grant or award | A | — 700 sh | Jul 2, 2026 traded Jul 1, 2026 |
| 9 | Mumford Gregory J.D.Chief Financial Officer | Option exercise | M | — 17.1K sh | Jul 2, 2026 traded Jun 30, 2026 |
| 9 | Advani LoveenChief Financial Officer | Option exercise | M | — 9,167 sh | Jul 2, 2026 traded Jun 30, 2026 |
| 8 | Bawel David BenjaminSVP & CHIEF ACCOUNTING OFFICER | Other acquisition or disposition | J | $8,256 515 sh | Jul 2, 2026 traded Jul 1, 2026 |
| 7 | Ribeiro RamiroChief Medical Officer | Option exercise · 10b5-1 plan | M | $20K 2,438 sh | Jul 2, 2026 traded Jun 30, 2026 |
| 6 | Finn Mark StevenDirector | Option exercise | M | — 2,344 sh | Jul 2, 2026 traded Jul 1, 2026 |
| 5 | Novack Jeffrey AdamSecretary and General Counsel | Tax withholding | F | $29K 997 sh | Jul 2, 2026 traded Jul 1, 2026 |
| 5 | Cordella Richard James JRDirector | Grant or award | A | — 2,652 sh | Jul 2, 2026 traded Jul 1, 2026 |
| 5 | O'Hara David MarkDirector | Grant or award | A | $19K 4,464 sh | Jul 2, 2026 traded Jul 1, 2026 |
| 5 | Doukeris Michel DDirector | Grant or award | A | — 130 sh | Jul 2, 2026 traded Jun 30, 2026 |
| 5 | Famularo Adam FrancisDirector | Grant or award | A | — 2,652 sh | Jul 2, 2026 traded Jul 1, 2026 |
| 5 | Liu Teyin MDirector | Grant or award | A | — 27 sh | Jul 2, 2026 traded Jun 30, 2026 |
| 5 | Narayanan ArunChief Executive Officer | Option exercise | M | — 8,125 sh | Jul 2, 2026 traded Jun 30, 2026 |
| 5 | O'Hara David MarkDirector | Grant or award | A | $13K 3,052 sh | Jul 2, 2026 traded Jun 30, 2026 |
| 4 | Katz ZacharyCLO and Head of Global Affairs | Open-market sale · 10b5-1 plan | SELL | $208K 12.8K sh | Jul 2, 2026 traded Jul 1, 2026 |
| 4 | Mecklenburg Gabriel M.I.Director, Exec. Chairman & Co-Founder | Open-market sale · 10b5-1 plan | SELL | $290K 3,500 sh | Jul 2, 2026 traded Jul 1, 2026 |
| 4 | Mecklenburg Gabriel M.I.Director, Exec. Chairman & Co-Founder | Open-market sale · 10b5-1 plan | SELL | $327K 3,900 sh | Jul 2, 2026 traded Jul 1, 2026 |
| 2 | Graham-Cumming JohnDirector | Grant or award | A | — 842 sh | Jul 2, 2026 traded Jun 30, 2026 |
| 2 | Finn Mark StevenDirector | Option exercise | M | — 2,344 sh | Jul 2, 2026 traded Jul 1, 2026 |
| 2 | Finn Mark StevenDirector | Grant or award | A | — 2,782 sh | Jul 2, 2026 traded Jul 1, 2026 |
| 0 | Ribeiro RamiroChief Medical Officer | Option exercise · 10b5-1 plan | M | — 2,437 sh | Jul 2, 2026 traded Jun 30, 2026 |
| 0 | Ribeiro RamiroChief Medical Officer | Option exercise · 10b5-1 plan | M | — 2,438 sh | Jul 2, 2026 traded Jun 30, 2026 |
| 0 | Mecklenburg Gabriel M.I.Director, Exec. Chairman & Co-Founder | Derivative conversion · 10b5-1 plan | C | — 83.3K sh | Jul 2, 2026 traded Jul 1, 2026 |
| 0 | Ribeiro RamiroChief Medical Officer | Option exercise · 10b5-1 plan | M | $20K 2,437 sh | Jul 2, 2026 traded Jun 30, 2026 |
| 0 | Bernstein HaroldPresident, R&D & CMO | Option exercise · 10b5-1 plan | M | — 14.6K sh | Jul 2, 2026 traded Jul 1, 2026 |
| 0 | Mecklenburg Gabriel M.I.Director, Exec. Chairman & Co-Founder | Derivative conversion · 10b5-1 plan | C | — 83.3K sh | Jul 2, 2026 traded Jul 1, 2026 |
| 0 | Schubach Sarah ElizabethChief Accounting Officer | Open-market sale · 10b5-1 plan | SELL | $35K 1,305 sh | Jul 2, 2026 traded Jun 30, 2026 |
| 0 | Bernstein HaroldPresident, R&D & CMO | Option exercise · 10b5-1 plan | M | $152K 14.6K sh | Jul 2, 2026 traded Jul 1, 2026 |
| 0 | Whalen Thomas GerardDirector | Grant or award · 10b5-1 plan | A | $2,505 102 sh | Jul 2, 2026 traded Jun 30, 2026 |
| 52 | Shen XiaojieDirector | Open-market purchase | BUY | $42K 2,436 sh | Jul 1, 2026 traded Jun 29, 2026 |
| 47 | Bhalla Narinder PalChief Medical Officer | Open-market sale | SELL | $99K 22.3K sh | Jul 1, 2026 traded Jul 1, 2026 |
| 47 | Vahland WinfriedDirector | Open-market purchase | BUY | $102K 6,000 sh | Jul 1, 2026 traded Jun 29, 2026 |
| 45 | Tpg Gp A, Llc10% Owner | NATPG Twin Brook Capital Income Fund Open-market purchase | BUY | $100.00M 3.97M sh | Jul 1, 2026 traded Jun 29, 2026 |